Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 USD | -0.31% | -6.16% | -84.39% |
04-15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
03-27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Ampio Pharmaceuticals, Inc.
Past events on Ampio Pharmaceuticals, Inc.
2023-11-02 13:10 | Emerging Growth Conference |
2023-10-05 15:25 | Emerging Growth Conference |
2023-09-11 | Reverse Split: 1 of 20 |
2023-07-27 12:00 | Annual General Meeting |
2022-11-09 | Reverse Split: 1 of 15 |
2022-10-13 13:00 | Extraordinary Shareholders Meeting |
2022-08-10 13:00 | Annual General Meeting |
2022-05-16 16:10 | Q1 2022 Earnings Release |
2022-04-28 08:00 | Business Update Call |
2022-03-29 16:30 | FY 2021 Earnings Call |
2022-03-29 16:10 | FY 2021 Earnings Release |
2022-03-15 16:30 | Roth Capital Partners Conference |
2022-03-02 16:30 | Business Update Call |
2022-01-10 07:00 | H.C. Wainwright BioConnect Conference |
2021-12-01 16:30 | Business Update Call |
2021-11-13 | American College of Toxicology Meeting |
2021-11-10 16:30 | Q3 2021 Earnings Call |
2021-11-10 16:01 | Q3 2021 Earnings Release |
2021-11-02 10:30 | International Society for Pharmaceutical Engineers Meeting |
2021-09-26 | Cantor Fitzgerald Global Healthcare Conference |
Past dividends on Ampio Pharmaceuticals, Inc.
2016-01-04 | 0 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -18,6 -18,2 -1.88% | -15,8 -15,3 -3.78% | -20,6 -15,2 -35.21% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -15,9 -15,2 -4.9% | -17,1 -14,8 -15.04% |
Net income Million USD | Released Forecast Spread | -13,6 -19,8 31.17% | -15,9 -15,2 -4.9% | -17,1 -15,0 -14.09% |
EPS USD | Released Forecast Spread | -30,0 -42,0 28.57% | -27,0 -27,0 0% | -27,0 -21,0 -28.57% |
Announcement Date | 21/02/20 | 03/03/21 | 29/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -9,23 -3,87 -138.36% | -6,97 -4,59 -51.93% | -4,99 -4,38 -13.88% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,22 -3,99 -55.91% | -5,64 -5,32 -5.86% | -2,07 -4,51 54.09% |
Net income Million USD | Released Forecast Spread | -6,22 -3,87 -60.81% | -5,64 -4,59 -22.88% | -2,07 -4,38 52.73% |
EPS USD | Released Forecast Spread | -12,0 -6,00 -100% | -6,00 -6,00 0% | -3,00 -6,00 50% |
Announcement Date | 29/03/22 | 16/05/22 | 09/08/22 |
Past sector events for Ampio Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AMPE Stock
- Calendar Ampio Pharmaceuticals, Inc.